Trial register facet
Trial records reported in 2022 — page 2
29 records with a recorded report or completion year of 2022.
Showing 0 records on this page
Records
29 documents · page 2 of 2
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| SURMOUNT-1-OLEprogramme record | Tirzepatide | Phase 3 | Reported | Single-arm open-label | — | 2022 | Very low |
| SURPASS-5 | Tirzepatide | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | 475 | 2022 | High |
| SURPASS-5-DDIprogramme record | Tirzepatide | Phase 1 | Reported | Randomised crossover | — | 2022 | Very low |
| SURPASS-5-PKprogramme record | Tirzepatide | Phase 1 | Reported | Phase 1 ascending dose | — | 2022 | Very low |
| SURPASS-5-RENAL-IMPprogramme record | Tirzepatide | Phase 1 | Reported | Phase 1 ascending dose | — | 2022 | Very low |
page 2 of 2